[{"Assets_0_Q2_USD":29794402.0,"CommonStockSharesOutstanding_0_Q2_shares":27070038.0,"NetIncomeLoss_1_Q2_USD":-5520307.0,"NetIncomeLoss_2_Q2_USD":-10516010.0,"StockholdersEquity_0_Q2_USD":27937585.0,"Ticker":"AADI","CIK":"1422142","name":"AERPIO PHARMACEUTICALS, INC.","OfficialName":"Aadi Bioscience Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339479977.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170810"}]